Article content

Ampliphi Biosciences Stock

Ampliphi Biosciences Stock 770% Upside From Current Price

Ampliphi Biosciences stock has rising large players volume after the company released incredible phase 1 trial results from their phage therapy cure for antibiotic resistant superbugs.